Skip to main content

Table 5 Summary of adverse events of second-line chemotherapy

From: Efficacy of second-line treatment and prognostic factors in patients with advanced malignant peritoneal mesothelioma: a retrospective study

Toxicity

Any Grade, n (%)

Grade 3/4, n (%)

Haematological toxicity

 Leukopenia

8 (30.8)

1 (3.8)

 Neutropenia

6 (23.0)

2 (7.7)

 Anaemia

14 (53.8)

3 (11.5)

 Thrombocytopenia

3 (11.5)

0 (0.0)

Non-haematological toxicity

 Nausea

7 (26.9)

0 (0.0)

 Vomiting

3 (11.5)

0 (0.0)

 Anorexia

7 (26.9)

0 (0.0)

 Fatigue

8 (30.8)

0 (0.0)

 Elevated creatinine

5 (19.2)

0 (0.0)

 Diarrhoea

2 (7.7)

1 (3.8)

 Constipation

5 (19.2)

0 (0.0)

 Skin rash

1 (3.8)

0 (0.0)

 Neurological disorder

3 (11.5)

1 (3.8)

 Dysgeusia

2 (7.7)

0 (0.0)

 Alopecia

3 (11.5)

0 (0.0)